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ABSTRACT

The effect of the specific beta-adrenergic receptor
agonist 1-isoproterenol on renin release and c-AMP content
of kidney slices from sodium-replete and sodium-deficient
rats was studied in vitro.

Male, Sprague-Dawley rats

weighing 210±1og were fed high sodium (over 2.2 mEg/L) or
low sodium (less than 0.02 mEg/L) diets for periods of time
of 2-3 weeks.

Following decapitation, renal cortical slices

weighing so±20mg were incubated for 1 hour at 37°C in
Robinson's buffer medium with or without (control) the
various pharmacological agents.

Isoproterenol doses ranging

from lo- 13M to 10- 3M did not affect renin release or c-AMP
content in slices from sodium-replete rats.

In contrast,

isoproterenol doses from 10- 7M to 10- 3M significantly increased renin release and c-AMP content in slices from
sodium-deficient rats, whereas concentrations lower than
10- 7M were ineffective.

Addition of the beta-adrenergic

receptor blocker d,l-propranolol (10 -4 M) to slices from
sodium deficient rats prevented stimulation of renin release
7
and c-AMP content by 10- M isoproterenol but only partially

inhibited the effect of a higher isoproterenol dose (10- 3M).
In the same slices, addition of the alpha-adrenergic receptor
blocker phentolamine (10

-6

M) prevented the stimulatory

effect of two isoproterenol doses
release.

(10

-7

M and 10

-3

M) on renin

Its effect on c-AMP content, however, was only

partial, since in the presence of phentolamine plus iso7
proterenol (10- M), tissue c-AMP content levels remained
significantly elevated.

It should be pointed out, however,

that although phentolamine appeared to prevent the stimulatory effect of 10

-7

M and 10

-3

M isoproterenol on renin

release, the mean renin secretory rates observed in the
presence of this blocking agent plus the two doses of
isoproterenol were no different from those seen with isoproterenol added alone, but the standard errors were larger
in the former.
These data indicate that:

1) sodium deficiency

potentiates the renin release and c-AMP responses to added
isoproterenol; 2) isoproterenol appears to stimulate renin
release in a dose-response relationship; 3) isoproterenol
stimulates renin release in sodium deficient rats by a
beta-adrenergic receptor mechanism mediated by the genera-

ii

tion of intracellular c-AMP; 4) alpha-adrenergic receptors
may partly mediate the stimulatory effect of isoproterenol
on renin secretion, instead of mediating an inhibitory
effect as proposed for high norepinephrine concentrations in
other studies.

iii
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CHAPTER I

INTRODUCTION

During the past decade, the importance of neural
sympathetic mechanisms in the regulation of renin secretion
has been clearly demonstrated in vitro (1-10) and in vivo
(11-15) and has been discussed at length in a number of
review articles (16-18).

Nevertheless, substantial progress

has been slowed by the difficulty of separating these neural
factors from the various humoral and hemodynamic ones
which influence renin secretion.

It is generally accepted

that renin secretion is partly regulated by norepinephrine,
the catecholamine released from sympathetic nerve terminals,
via a beta-adrenergic receptor complex.

This complex

appears to be located on the membranes of the juxtaglomerular cells themselves, and may utilize cyclic-3'5'adenosine monophosphate (c-AMP) as the intracellular
mediator of renin release by norepinephrine.
Several studies (7, 9, 10, 15) have also shown
that in addition to its stimulatory effect on renin release
at physiological and subphysiological concentrations which

2
appears to be beta-receptor mediated, high concentrations of
norepinephrine may exert an inhibitory effect on renin
release.

This inhibitory effect of norepinephrine on renin

release may be mediated by renal alpha-adrenergic receptors
(8, 9, 15) through a decrease in intracellularly generated
c-AMP (9).

The significance of these opposite effects of

norepinephrine on renin release is not clear at this
time.
This investigation examines some of the mechanisms
by which the sympathetic nervous system regulates renin
secretion from the juxtaglomerular cells of the mammalian
kidney.

Although this research is basic in nature it has

important clinical implications as well, particularly with
regard to hypertensive disorders characterized by a chronic
maladjustment of the renin secretory mechanisms (i.e.
high-renin hypertension) which may be neurally mediated to
a significant degree (18, 19).
Overall, these experiments are designed to evaluate the effects of a specific beta-adrenergic receptor
agonist, isoproterenol (20), either alone or coupled with
alpha- and beta-adrenergic receptor blockade on renin
release.

Examination of these effects has been accomplished

3

by means of an in vitro rat renal cortical slice preparation, obtained from rats maintained on sodium-replete or
sodium-deficient diets for 2-3 weeks (7, 9).
Specifically, these experiments will attempt to
determine whether or not:

1) isoproterenol stimulates renin

secretion primarily via a beta-adrenergic receptor pathway,
mediated by c-AMP and involving new synthesis of renin as
suggested for norepinephrine (4, 5, 7, 9) rather than by a
preferential membrane effect not involving de

~

synthesis

of renin (21); 2) beta-adrenergic receptor blockade by
d,l-propranolol inhibits isoproterenol-stimulated renin
release, as suggested for norepinephrine and other catecholamines (4); 3) renal alpha-adrenergic receptors play a
role in inhibiting isoproterenol-stimulated renin release,
as recently suggested by some investigators regarding
norepinephrine (8, 9); 4) there is a correlation between
c-AMP and renin release changes in response to isoproterenol,
which would constitute strong evidence for a beta-adrenergic
receptor pathway mediating renin secretion via intracellularly generated c-AMP and de

~

synthesis of renin; and

5) sodium deficiency potentiates the renin secretory
responses to isoproterenol, as suggested from various in

4

vivo and in vitro studies with regard to other catecholamines (9, 12).

CHAPTER II

LITERATURE REVIEW

It is now well established that renin release is
regulated by several interrelating factors.

These factors,

described by Davis (17), include the following:

1) the

intrarenal receptors, composed of the baroreceptors of the
renal afferent arteriole, and the macula densa natrioreceptors located in the walls of the distal convoluted
tubule of the kidney; 2) humoral agents such as sodium,
potassium, calcium, antidiuretic hormone, angiotensin-II,
c-AMP and the circulating catecholamines epinephrine and
norepinephrine from the adrenal medulla; 3) the sympathetic
nervous system, via catecholamines released from renal
sympathetic nerve endings.
A.

The Renin-Angiotensin System

Renin, a hormone synthesized and released from the
juxtaglomerular cells of the afferent arteriole of the
kidney, is involved in the control of blood pressure, fluid
volume and electrolyte balance (17, 22-26).

That the jux_

taglomerular cells are indeed vascular smooth muscle

5
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cells modified to serve an endocrine function was first
suggested by Goormagtigh (27).

Laragh (26) and Liddle et.

al (28) have recently reviewed the renin-angiotensin system
biochemical pathway, which is initiated by endogenous renin
acting enzymatically on the tetradecapeptide angiotensinogen
(renin substrate), a gamma globulin synthesized in the
liver, to liberate the decapeptide angiotensin-! by hydrolysis of the C-terminal tetrapeptide of angiotensinogen.
Angiotensin-! in turn is cleaved by a converting enzyme
found in large amounts in the pulmonary circulation,
liberating the octapeptide angiotensin-II, considered to be
the most powerful pressor agent in the systemic circulation.
In addition to its effects on blood pressure, angiotensin-II has been postulated as being a potent stimulator of
the synthesis and secretion of aldosterone, a mineralocorticoid from the adrenal cortical glomerulosa cells (2,
29).

However, recent evidence by Vaughan (30) have sug-

gested that angiotensin-III, a circulating heptapeptide
derived from angiotensin-II, may be the actual modulator of
aldosterone synthesis and release.

7

B.

Intrarenal Receptors

Tobian et. al (22) have suggested that a decreased
stretch of the afferent arteriole as a result of changes
in perfussion pressure, leads to an increase in renin release.
Using a non-filtering, denervated kidney coupled with adrenalectomy, which effectively eliminated macula densa, renal
nerve catecholamines and circulating catecholamine effects,
respectively, Blain and Davis (25) observed a significant
increase in renin release in response to a moderate hemorrhage
(20ml/kg), thus supporting the baroreceptor hypothesis.
Vander and Miller (31) first suggested that the
macula densa cells of the distal convoluted tubule are
sensitive to changes in sodium "load" or concentration.

In

their experiments with anesthetized dogs, they observed that
the increase in renin secretion caused by aortic constriction was no longer seen upon administration of diuretic
agents.

They therefore suggested that diuretic agents

increase the sodium load at the macula densa thus inhibiting
renin release.

They further proposed that renin release is

stimulated by a decreased sodium load at the macula densa,
and that the macula densa cells function as effective natrioreceptors.

Nash (32) has supported this macula densa theory

8
this macula densa theory by showing that in dogs having
their ureters blocked, infusion of sodium chloride solutions
resulted in a significant decrease in renin secretion.
C.

Humoral and Hemodynamic Effects on Renin
Release

Further experiments by Vander (33) on the effects
of potassium on renin secretion have shown that infusion
of potassium chloride solutions into normal or salt-depleted
dogs caused a decrease in renin release.

Potassium is

postulated to inhibit renin release indirectly by inhibiting
proximal tubule sodium reabsorption which would, in turn,
increase the sodium load at the macula densa.
Furthermore, Michelakis et. al (1) have shown that
c-AMP added to incubated kidney cell suspensions resulted
in a greater net production of renin than cells incubated
without c-AMP, suggesting a possible direct effect of this
nucleotide on renin secretion.

More recent investigations

by Saruta et. al (34) have provided added evidence for a
stimulatory role of c-AMP on renin secretion.

The same

workers have additionally suggested that calcium also
plays a stimulatory role on renin release.

However, most

of the evidence concerning the possibility of a direct

9

effect of ions on renin release is still controversial and
further studies are clearly needed.
The mechanisms by which angiotensin-II and antidiuretic hormone (ADH) inhibit renin release have been
reviewed by Shade et. al (35).

Using sodium-depleted dogs

with a nonfiltering kidney they found a decrease in renin
secretion after infusion of angiotension-II and ADH, suggesting that the action of these humoral agents may be
exerted directly on the juxtaglomerular cells, which supports
previous work by Bunag et. al (11).

While the possibility

of a direct mechanism of action of ADH on renin secretion
remains largely unclear, these studies and others (9) generally show that angiotensin-II appears to exert a direct
regulatory control over renin release by a short-loop negative feedback of locally-generated angiotensin-II on the
juxtaglomerular cells.

It has also been suggested that this

inhibitory effect of angiotensin-II is mediated by a decrease
in intracellularly generated c-AMP (9).
D.

The Sympathetic Nervous System and Renin
Secretion

Evidence is accumulating that the sympathetic
nervous system is a very important modulator of renin

10
secretion, not only for the minute-to-minute control in
the healthy individual, but in pathological states as well
(18, 19, 36).

Electron microscopic (37) and fluorometic studies
(38) have provided clear evidence for a dense sympathetic
innervation of the juxtaglomerular cells, suggesting the
possibility of a direct stimulation of renin secretion by
released norepinephrine from sympathetic nerve endings and
perhaps by its released precursors (dopamine) as well.
In vivo experiments by Vander (39) confirmed these early
observations by showing that electrical stimulation of the
renal nerves significantly increased plasma renin activity.
Johnson et. al (40) have supported these findings by
showing that direct stimulation of the renal nerves resulted
in a concomitant increase in renin secretion.

Passo et. al

(41) additionally found that stimulation of the medulla
oblongata increased plasma renin activity and that this
response was prevented by renal dennervation.
Investigations concerning the effects of catecholarnines on renin release (17) have shown that the
circulating catecholamines epinephrine and norepinephrine
released from the adrenal medulla, as well as norepine-

11

phrine released from renal sympathetic nerve endings,
stimulate renin release and that this reponse may be mediated by a beta-adrenoreceptor pathway.

Evidence for the

existence of a beta-adrenoreceptor mechanism mediating renin
release has been obtained from the studies of Loeffler et.
al (42) who showed that in dogs given 1-propranolol, a known
beta-adrenoreceptor blocker, renin release produced by renal
nerve stimulation was significantly decreased.

Moreover,

Assaykeen et. al (13) observed that as a result of hypoglycemia produced in dogs, which increased the levels of
circulating catecholamines, renin secretion was abolished
upon injection of 1-propranolol.

The same workers addi-

tionally showed that following administration of phentolamine, an alpha-adrenorector blocker, renin secretion was
potentiated above control levels.
However, these in vivo findings cannot eliminate the
possibility of other in vivo factors participating in the
observed responses.

Thus, in order to evaluate the possi-

bility of a direct action of the sympathetic nervous system
on renin secretion, in vitro systems have been designed
which effectively eliminate the contribution of humoral,
hemodynamic and other in vivo influences.

Using an in

12
vitro renal cortical slice preparation, Nolly et. al (4)
have shown that added norepinephrine stimulates renin
release, and that this stimulation appears to be mediated by
a beta-adrenoreceptor complex located on the membranes of
the juxtaglomerular cells.

Furthermore, Nolly et. al.

(4)

provided additional evidence for their postulation by
showing that the addition of theophylline, an inhibitor of
the phosphodiesterase enzyme that ordinarily degrades
intracellular c-AMP (43), resulted in a potentiation of the
renin release responses to added norepinephrine.

This

suggests that norepinephrine may exert its action on renin
release via a beta-adrenoreceptor mechanism which utilizes
c-AMP as the intracellular mediator.

Numerous other in

vitro workers are in agreement with this proposed mechanism
of action (1, 5-7, 44).

Nolly et. al (4) have also shown

that norepinephrine-stimulated renin release is potentiated
by the addition of phentolamine and phenoxybenzamine, both
of which are alpha-adrenoreceptor blocking agents.

This may

suggest a contribution of alpha-adrenoreceptors in the
regulation of renin secretion which may be inhibitory in
nature.

13
These in vitro observations have been further
extended by Ganong and Lopez (9) who showed that the significant stimulatory effect of low (lo-

12

7
M to 10- M) nore-

pinephrine doses on in vitro renin secretion in sodiumdeficient rats was accompanied by concomitant increases in
tissue c-AMP content.

This constitutes additional evidence

for a beta-adrenoreceptor mechanism mediating renin
secretion.

Conversely, the same workers have shown that

4
high (10- M) norepinephrine doses were inhibitory to renin
release and that this response is coupled with a significant
decrease in tissue c-AMP levels.

They have suggested, as

well as others (3, 8, 15), that this inhibitory effect of
high norepinephrine concentrations on renin release may be
alpha-adrenoreceptor mediated since simultaneous addition of
specific alpha-adrenoreceptor blockers (e.g. phentolamine)
effectively reversed the inhibition (8, 9).
On the other hand, Winer et. al (45) have presented
evidence suggesting that alpha-adrenoreceptors actually
mediate the stimulatory effect of catecholamines on renin
secretion.
In vitro studies by Ganong and Lopez (9) have shown
that the renin secretory responses to added norepinephrine
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are potentiated under sodium-deficient conditions, supporting previous in vivo data (12).

Most studies pertaining

to renin secretion have utilized animals maintained on a
commercial chow diet.

However, a commercial chow diet

contains approximately 12 times the recommended amount of
sodium by the National Research Council.

This obviously

would result in a much lower basal renin release in these
animals since renin release is extremely sensitive to plasma
sodium levels.

On the other hand, animals maintained on

sodium-deficient diets show a much higher rate of basal
renin release (7, 46) which appears to be due to an increased de

~

synthesis; this has been shown by the elegant

electron microscopic studies of Reidel (47).

Moreover, in

vivo (11, 12) and in vitro studies (7, 9) have suggested
that sodium-deficient conditions, in addition to increasing
the basal renin secretory rate, potentiate the renin secretory reponses to sympathetic stimuli.

Thus, the evaluation

of both stimulatory and inhibitory effects of various
adrenergic agents on renin secretion in animals maintained
on sodium-deficient diets may be more easily ascertained, in
view of the apparent greater sensitivity of the juxtaglomerular cells coupled with the higher resting renin release
rates seen in the sodium-deficient state.

15
E.

Isoproterenol and Renin Secretion

Numerous studies on the effects of isoproterenol,
a catecholamine with postulated specific beta-adrenoreceptor
stimulating properties (20), have presented conflicting
evidence as to the actual mechanism mediating its stimulatory effect on renin secretion.
In vitro studies by Weinberger et. al (5) have shown
that isoproterenol stimulates renin release and that this
effect is blocked by the addition of 1- and d,l-propranolol
but not by d-propranolol, which has all the properties of
1-propranolol except its beta-blocking ability.

Similar

results have been reported by Capponi and Valloton (8} who
showed that the significant stimulatory effect of isoproterenol on renin release was inhibited by d,l-propranolol,
which constitute clear evidence for a beta-adrenoreceptor
mechanism of action of this catecholamine.

Other investi-

gators (44, 48) have further suggested that the stimulatory
effect of isoproterenol on renin secretion is mediated by
changes in intracellularly generated c-AMP and involves de
novo synthesis of renin; this is consistent with a betaadrenoreceptor mechanism of action.

16
Assaykeen et. al (49) have also shown in anesthetized
dogs that administration of phentolamine during isoproterenol
infusion did not cause a reduction in renin.

However, the

addition of 1- and d,l-propranolol effectively prevented the
increase in renin secretion seen during isoproterenol infusion.
These data add support to a beta-adrenoreceptor mediated
mechanism of action.
In contrast to the possibility of an adenylate-cyclase
complex mediating the renin release responses to isoproterenol,
Johns and Singer (21) have indicated that the stimulatory
effect of isoproterenol on renin release may preferentially
be a membrane effect.

They indicate that this leads to the

output of preformed cytoplasmic renin granules without any
involvement of an adenyl-cyclase-containing receptor complex;
thus, without de

~

synthesis of renin.

Partially in

agreement with this view is the work by Beck (50) who has
suggested that the renin-releasing effect of isoproterenol
can be dissociated from the renal increase in c-AMP.
Conversely, Reid et. al (14) have reported that
although intravenous infusion of isoproterenol caused a
significant increase in renin secretion, no increase was
observed during intrarenal infusion.

They, therefore,
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suggested the existence of an extrarenal receptor mechanism
mediating the renin secretory responses to the infused
isoproterenol, the location of which has not been proposed.
In any case, isoproterenol may eventually be considered
to be another important regulator of renin secretion, particularly in view of the finding by Lockett et. al (51) of a
substance that appears to be isoproterenol in the extracts
of rat adrenal glands.

This suggests the interesting possi-

bility that isoproterenol may be an endogenous secretory
product of the adrenal medulla, and thus capable of participating in the minute-to-minute regulation of renin secretion
in the body.

CHAPTER III

~~TERIALS

AND METHODS

Male, Sprague-Dawley rats (Sprague-Dawley, Co.)
weighing 210±1og were utilized for the exper~ents.

They

were maintained in temperature-controlled rooms (23±2°C),
two animals per cage, and had access to distilled-deionized
water ad libitum.

The animals were divided into two groups

of 24 each, which were subsequently studied in two different
experimental trials.

The first group of 24 rats was further

divided into two equal subgroups, each subjected to a specific
dietary regime in which sodium was the only variable.

Thus,

one subgroup of 12 rats was fed a normal sodium chow diet
(Purina) for 2-3 weeks while the other subgroup was fed a
sodium-deficient diet (TEKLAD TEST, Co.) for a similar
period of time.

The second group of 24 rats, utilized in

later experiments, was fed only a sodium-deficient diet for
a period of 2-3 weeks.
At the end of the specific dietary intake period,
animals from the first group were sacrificed by decapitation, and their kidneys rapidly excised, decapsulated and
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gassed with a mixture of 95% o 2 -5% co 2 (52) while being
maintained in Robinson's buffer medium at 4°C.

Slices of

renal cortex approximately 0.3mrn thick were prepared using a
Stadie-Riggs microtome (A. Thomas, Co.) and divided into
five similar portions, each weighing approximately so±2omg,
which were randomly assigned to incubating flasks to assure
a homogeneous population of cells.

The slices were then

preincubated for 15 minutes in 2.5ml of Robinson's buffer
medium at 37°C in an atmosphere saturated with 95% o 2 -5%

co 2 using a Dubnoff shaking incubator (Precision Scientific,
Co.).

They were subsequently transferred to similarly

numbered flasks containing fresh Robinson's at 37°C at which
time the catecholamine was added.

L-Isoproterenol (Sigma),

prepared in 0.1% ascorbic acid to prevent oxidation of the
catecholamine (5), was added in concentrations ranging from
lo-

13

M to 10- 3M in order to test for a dose response.

This

was followed by a 60 minute incubation period at 37°C with
continuous 95% o 2 -5% co gassing and shaking.
2

One flask

from each group of slices served as an untreated control.
After one-hour incubation the supernatant medium was collected and stored at -20°C until assayed, while the tissue was
immediately frozen on dry-ice, homogenated in l.Oml of 8%
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TCA (trichloroacetic acid) and subsequently extracted with
water-saturated ether (Mallinckrodt) .

The ether phase was

then discarded and the c-N1P containing water phase was
subsequently lyophyllized and measured for c-AMP content
using a modification of the competitive protein binding
assay of Gilman (53).
follows:

Briefly, the assay was performed as

fifty microliters of the unknown lyophyllized

samples, previously diluted in 250 microliters of buffer
(Tris/EDTA), were analyzed in duplicate along with 100
microliters of binding protein purified from bovine muscle
(Amersham) and 50 microliters of

3

H-c-AMP (Amersham).

The

samples were then incubated for 90 minutes at 4oc· at which
time 200 microliters of charcoal suspension (Amersham) were
added which separated protein-bound from free c-AMP.

The

samples were then vortexed for 5 seconds and immediately
centrifuged in a Sorvall RC2-B refrigerated centrifuge for
10 minutes at 10,000 X G, also at 4°C.

At this time 200

microliters of the supernatant were transferred into counting
vials (Scientific Products) containing 10.0 ml of ACS-liquid
scintillation cocktail (Amersham) , shaken and then allowed
to settle in the dark for approximately 30 minutes prior to
counting.

Counting was done in a Packard liquid scintillation
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counter for 5 minutes with the background counts subtracted.
The values for the unknown samples were read from a standard
curve and the amount in picomoles of c-AMP (read off the
curve) were multiplied by a factor of 5 (i.e. dilution
factor due to 1:5 dilution of sample in Tris/EDTA buffer)
and divided by the milligrams of wet tissue weight to give
the final concentration in pmol c-AMP content/mg wet tissue.
In turn, renin in the incubated supernatant medium
was measured by radioimmunoassay (RIA) of angiotensis-I and
expressed as nanograms A-I generated/mg wet tissue/hour
incubation.

The supernatant samples were prepared for the

RIA desribed as follows:

plasma from 24-hour nephrectomized

dogs was utilized as the source of renin substrate (angiotensinogen) .

Appropriate amounts of the converting enzyme-

angiotensinases inhibitor agent, PhenylMethylSulfonylFluoride
(Sigma) , were added to the nephrectomized plasma to prevent
catabolism of angiotensin-! or its conversion to angiotensin-II.

One milliliter of this mixture was added to 25

microliters of sample (renin-supernatant) , and angiotensin-! was generated for 2 hours in a water bath at 37°C.

At

the end of the 2-hour generation period, one ml of distilleddeionized water was added to the tubes and the samples were
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then boiled for three minutes.

The samples were subse-

quently stored at -20°C until assayed for angiotension-I by
RIA (Squibb).
follows:

In short, the angiotensin-! RIA was done as

duplicate tubes containing unknown amounts of

sample (25, 50, or 100 microliters), one ml of
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r-Angio-

tensin-I (approximately 5,000 counts per minute) and 50
microliters of angiotensin-! antiserum were incubated at 4°C
for 24 hours.

At this time, one ml of charcoal suspension

adjusted to ph 5.5 with O.lN HCl were added to separate
antibody-bound from free angiotensin-!, vortexed for 5
seconds and centrifuged for three minutes at 10,000 X G at
4°C.

The supernatant was then transferred to test tubes

(Scientific Products) and counted in a gamma counter (Packard) for two minutes with the background counts subtracted.
Percent-bound values for the unknown samples were used as an
index to determine the picogram amounts of angiotensin-!
from a standard curve.

The final angiotensin-! concen-

tration in the unknown samples were expressed as ng A-I
generated/mg wet tissue/hr (see Appendix A).
Slices of renal cortex from the second group of rats
were similarly prepared and divided into six similar portions with one serving as control.

They were also treated

in the same manner as those from the first series of studies.
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However, in this instance, a specific beta-adrenoreceptor
blocker d,l-propranolol (Sigma), prepared in 0.1% ascorbic
acid to a concentration of 10

-4

M, and an alpha-adreno-

receptorblocker, phentolamine mesylate (Regitine, CIBA),
also prepared in 0.1% ascorbic acid to a concentration of
10- 6M, were added both before the pre-incubation (15 min.)
and incubation (60 min.) periods.

These agents were evalu-

ated when added either alone or in the presence of four
9
different isoproterenol concentrations (lo- 11 , 10- , 10- 7 ,
and 10- 3 M).

Supernatant and tissue samples were collected,

prepared and stored in a manner identical to those from the
first series of studies and subsequently analyzed for the
same parameters as previously described.
The data collected from these series of studies were
analyzed for statistical significance using a modified
paired student's T test (54) with the aid of a desk-top
programmable calculator (Hewlet-Packard).

CHAPTER IV

RESULTS

In a preliminary investigation, the effect of
dietary sodium changes on renin release and the c-AMP
content of rat kidney tissue was examined using the previously described renal cortical slice preparation.
data can be seen in Figure 1.

These

As observed, the basal,

non-stimulated, renin release rate in slices from sodiumdeficient rats was significantly greater (p 0.01) than that
seen in slices from sodium-replete animals.

There were not

significant differences, however, between both dietary
groups of slices in regard to the c-AMP content of the
tissue in response to dietary sodium manipulation.
In a subsequent study, the effect of various concentrations of the specific beta-adrenergic receptor agonist
1-isoproterenol on renin secretion and c-AMP content of
renal cortical slices from sodium-replete rats was evaluated.

The results can be seen in figure 2.

The data from

this experiment shows that at these various concentrations
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lating renin release from the incubated kidney slice tissue.
However, it is also apparent from these data (figure 2) that
as the concentration of isoproterenol was progressively
increased, the mean renin secretory values of the isoproterenol-treated slices became increasingly greater than the
mean values of the non-stimulated control slices.

In the

same study, changes in c-AMP content of the kidney slices in
response to the same concentrations of isoproterenol (figure
3) were also not significantly different from controls, an
observation which is consistent with the renin secretory
responses shown in figure 2.
Significant changes in the parameters examined were
observed in another study, when isoproterenol at various
concentrations (10

-13

M to 10

-3

M) was added to kidney slices

from sodium-deficient rats (figure 4).

As shown in this

figure, although isoproterenol doses of 10- 9M or lower were
still ineffective in stimulating renin secretion, higher
concentrations of this catecholamine (10- 7M, 10- 5 M, l0- 4r-1,
and 10- 3 M) significantly stimulated renin release, with the
highest mean renin release values seen at a concentration of
5
10- M).

A statistical comparison among the four stimulatory
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concentrations of isoproterenol indicated, however, that
there were not significant differences between them in
regard to stimulation of renin secretion.

When their

effects on renin release were compared to those exerted by
lower isoproterenol concentrations (10

-12

dose-response relationship was apparent.

M to 10

-9

M) a

Thus, maximal

stimulation of renin secretion was achieved with an isoproterenol dose as low as 10- 7M; higher doses were ineffective
in further potentiating the stimulatory effect (figure 4).
When the renin release responses to added isoproterenol (figure 4) were compared with those exerted by the
same concentrations of this catecholamine on tissue c-AMP
content (figure 5), an apparent positive correlation between
these two parameters was observed.

These data show that at

concentrations of 10- 7M, 10- 5M, and 10- 3M, isoproterenol
significantly stimulated both renin release and the c-AMP
content of renal slices from sodium deficient rats.

At 10- 4M

concentration, however, isoproterenol exerted a significant
stimulatory effect only on renin release but not on c-AMP
content.

As expected, changes in c-AMP content of the

isoproterenol-treated tissue slices were not significantly
different from controls at isoproterenol concentrations of
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9
10- M or lower.

This is consistent with the changes seen in

renin secretion in response to the same doses of this catecholamine (figure 5).
Data from a subsequent study designed to further
evaluate the extent of beta-adrenoreceptor control of renin
release are depicted in figure 6.

This figure shows the

changes observed in renin release and c-AMP content of
slices from sodium-deficient rats in response to four
isoproterenol doses (lo- 11 M, 10- 9M, 10- 7M, and 10- 3M), added
either alone or in conjunction with a 10- 4M concentration of
the beta-adrenoreceptor blocking agent d,l-isoproterenol.
As expected, when added together with two isoproterenol
doses (10

-11

M and 10

-9

M) which by themselves were ineffective

in stimulating either renin release or c-AMP content, propranolol did not affect the response observed with isoproterenol alone.

Conversely, when propranolol was added in

conjunction with a 10- 7M isoproterenol dose, it significantly inhibited the stimulatory effect of this concentration of isoproterenol on renin release and c-AMP content.
3
When added together with a higher isoproterenol dose (10- M),
however, propranolol at the concentration used (10

-4

M) was

unable to inhibit the significant stimulatory effect of this
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catecholamine on renin secretion, although it did prevent
the increase in c-AMP content seen with this dose of isoproterenol added alone.

Surprisingly, addition of propranolol

by itself to the slice preparation significantly decreased
the c-AMP content of the tissue in relation to the nonstimulated control samples, although it did not significantly affect renin secretion as compared to control values.
Table 1 illustrates the results of an additional
study designed to evaluate the effect of the alpha-adreno6
receptor blocking agent phentolamine (10- M), on the renin
release and c-AMP content responses to four isoproterenol
doses (10

-11

M, 10

-9

M, 10

sodium-deficient rats.

-7

M, and 10

-3

M) in slices from

Although when added alone to the

slice preparation, phentolamine did not alter renin secretion or c-AMP content levels in relation to those of controls, it did partially prevent the stimulatory effect of

.
1 concentrat1ons
.
.
10 -? M an d 10- 3M 1soprotereno
on ren1n
release when added in conjunction with the catecholamine.
However, the c-AMP content of slices treated with 10- 7 M
isoproterenol plus 10- 6 M phentolamine remained significantly
elevated in relation to controls, but it appeared no different from controls in response to 10 -3 M isoproterenol
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added in conjunction with phentolamine.

It should be noted,

however, that the mean renin secretion change levels of
7
slices treated with 10- M and 10- 3M isoproterenol in conjunction with phentolamine, were equal to or greater than
the statistically significant ones observed in response to
the same doses of isoproterenol added alone, but the standard errors were larger in the former.

From these data

(Table 1), it is also clear that at no time phentolamine
potentiated the effects of any of the isoproterenol doses on
renin secretion or c-AMP content of the slice tissue, when
added together with the catecholamine.

11

-9

-7

TABLE I:
Effect of various doses of isoproterenol (10- M, 10 M, 10 M, 10-JM) in the presence and
absence of phentolamine (10- 6 M) on renin secretion and c-AMP content of kidney slices from sodiumdeficient rats.
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..

+
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CHAPTER V

DISCUSSION

A renal cortical slice preparation of the type
described in this study allows one to eliminate the various
humoral and hemodynamic factors which are known to influence
renin release in the intact animal.

Thus, the effects of

sympathetic stimuli on renin release may be considered to be
exerted directly on the juxtaglomerular cells present in an
in vitro kidney slice system (5, 7, 44).

Furthermore,

animals maintained on sodium-deficient diets have shown an
increased basal resting renin release rate (12, 46), as
compared to animals fed a sodium-replete diet.

In addition,

sodium-deficiency has been shown to potentiate the renin
release responses to sympathetic stimuli (5), which makes a
cortical slice preparation obtained from sodium-deficient
rats an ideal tool for a clear evaluation of the effects of
adrenergic agents on renin secretion.
The results obtained in an initial study (figure 1)
confirm previous data (9, 12) which indicate that the resting
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renin release rate in kidney slices of rats maintained on a
sodium deficient diet is significantly higher than that seen
in sodium-replete animals.

These results (figure 1) also

show that sodium-deficiency did not alter the c-AMP content
levels of the tissue slices, suggesting that the increased
resting renin secretory rates observed under low sodium
conditions may not be mediated by changes in the intracellular concentration of this nucleotide.
In a subsequent study designed to examine the renin
secretory responses to sympathetic stimuli in the sodiumreplete state various concentrations (lo- 13 M to 10- 3M) of
the specific beta-adrenoreceptor agonist 1-isoproterenol
added to kidney slices from sodium-replete rats were evaluated.

These results (figure 2) indicate that although the

mean renin release responses to increasing isoproterenol
doses (10

-7

M to 10

-3

M) were consistently higher than control

values, the increases were not of sufficient magnitude to be
statistically significant.

Similar results were observed in

regard to tissue c-AMP changes in slices from sodium-replete
rats in responses to the same concentrations of isoproterenol (figure 3).
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The inability of the tissue slice preparation
obtained from sodium-replete rats to respond to isoproterenol stimulation in this study is not surprising, since
renin secretory mechanisms are very sensitive to sodium
changes and these animals had ingested a diet providing over
2.2 mEq of sodium per day, which is about 12 times the
amount of sodium recommended by the National Research
Council for growing rats.

Our results are supported by the

work of Nash (24, 32) in which infusion of sodium chloride
in live dogs resulted in a significant decrease in renin
secretion.

Thus, it appears that the increased sodium

content of the diet fed to the animals used in this study is
most likely responsible not only for the low levels of renin
secretion observed in renal slices from these animals, but
also for the lack of responses of the slice tissue to
isoproterenol stimulation.
In another study, the effects of various concentrations (10

-13

M to 10

-3

M) of 1-isoproterenol on renin

release in kidney slices from sodium-deficient rats were
evaluated (figure 4).

As opposed to the results observed in

tissue slices from sodium-replete rats upon addition of
isoproterenol, four concentrations of this catecholamine

40

3
(10- 7 M, 10- 5 M, 10- 4M, and 10- M) significantly stimulated
renin release in slices from sodium-deficient rats.

At no

time was inhibition of renin release by high isoproterenol
doses seen in this study, as opposed to that seen with
norepinephrine in other studies (7, 9).

These data (figure

4) support previous in vivo (11, 12) and in vitro (7, 9)
observations, suggesting a potentiation of the renin secretory
responses in sympathetic stimuli in

sodium~deficient

animals.

Furthermore, these results show a clear dose-response relationship which rules out leakage of renin from the cells as a
contributing factor in the responses observed.
When the renin release responses to the four stimulatory concentrations of isoproterenol are compared to the
c-AMP content changes seen in response to the same isoproterenol doses (figure 5), a clear correlation between these
two parameters can be observed.

These results provide

strong support for the concept that stimulation of renin
secretion by catecholamines is mediated by a beta-adrenoreceptor
mechanism which utilizes intracellularly generated c-AMP as
a second messenger of the catecholamine action.

In addition,

these data (figure 5) are in agreement with previous work
(7, 9) which have shown a correlation between renin release
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and c-AMP content changes in response to norepinephrine
added to kidney slices from sodium-deficient rats.
To further extend these observations, the effect of
the specific beta-adrenoreceptor blocking agent d,l-propranolol (10- 4M}, added either alone or in conjunction with
isoproterenol, on renin release and tissue c-AMP content of
slices from sodium-deficient rats was examined (figure 6}.
These results support previous findings (1, 10, 42, 49}
indicating that propranolol suppresses the stimulatory
effect of catecholamines on renin secretion.

This inhibition

can clearly be seen in this study at an isoproterenol dose
of 10
(10

-3

-7

M, although a higher concentration of this catecholamine

M} appeared to be sufficiently potent to override the

inhibitory effect of propranolol at the concentration used
4
(10- M}.

These data (figure 6) also present evidence for

the first time clearly linking the inhibitory effect of
propranolol on renin secretion with a simultaneous inhibition
of tissue c-AMP content, which strongly support the concept
that catecholamine stimulation of renin secretion is mediated
by a beta-adrenoreceptor complex most likely located on the
membranes of the juxtaglomerular cells themselves.
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Interestingly, propranolol (10

-4

M) added alone to

the tissue slice preparation (figure 6) significantly inhibited
c-AMP content levels in relation to those seen in control
(non-treated), slices, and mean renin secretory rates in
response to this blocking agent also appeared decreased but
not significantly.

These observations suggest that endo-

genous catecholamines still present in the cortical slice
tissue, contribute to the regulation of basal renin secretion in the sodium-deficient state.
The results obtained in an additional study involving
the use of the specific alpha-adrenoreceptor blocking agent
phentolamine are inconclusive (Table 1).

Numerous studies

(4, 7-9, 15) have shown that alpha-adrenoreceptor blockade
potentiates the renin secretory responses to sympathetic
stimuli.

In our studies phentolamine did not potentiate but

rather prevented the stimulatory effect of two isoproterenol
doses (10

-7

3
M and 10- M) on renin release.

Its effect on

tissue c-AMP content, however, was only partial since in the
presence of phentolamine (10

-6

M) plus isoproterenol (10

-7

M),

tissue c-AMP content levels remained significantly elevated.
It should be pointed out, however, that although phentolamine appeared to prevent the stimulatory effect of 10- 7 M
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and 10

-3

M isoproterenol on renin release, the mean renin

secretory rates observed in the presence of this blocking
agent concomitant with two different doses of isoproterenol
were no different from those seen with isoproterenol added
alone, but the standard errors were larger in the former.
Thus, statistics notwithstanding, one could suggest that
stimulation of renin secretion by isoproterenol with simultaneous addition of phentolamine was maintained to a certain
degree, but that it certainly was not potentiated.

Further

studies utilizing additional doses of phentolamine are
clearly needed to further evaluate the responses observed in
our study at the concentration of phentolamine used.
In summary, the data presented in this thesis
supports the view that sodium deficiency, in addition to
significantly increasing basal renin release, potentiates
the renin secretory responses to sympathetic stimulation in
rat renal cortical slices.

This increase in basal renin

secretory levels as a result of sodium deficiency appears
not to involve changes in tissue c-AMP content.
Furthermore, these results offer clear evidence for
a beta-adrenoreceptor mechanism mediating the effect of
isoproterenol on renin release, and strongly suggests that
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this mediation is exerted through changes in intracellularly
generated c-AMP.
Additionally, the effect of isoproterenol on renin
release and c-AMP content appears to be dose-dependent, and
at no time did higher doses of this agent cause inhibition
of either parameter as suggested for large concentrations of
norepinenephrine in previous studies.

This observation is

consistent with the view that alpha- receptors do not participate in mediating the effect of large concentrations of
isoproterenol on renin secretion, a role which appears to be
inhibitory in nature in regard to high norepinephrine doses.
If anything, our data pertaining to phentolamine
would rather support the idea that alpha- adrenoreceptors
partly mediate the stimulatory effect of isoproterenol on
renin secretion instead of an inhibitory effect.

Additional

studies with this alpha- adrenergic blocker are needed
before a more conclusive statement in this regard can be
made.
Finally, the data obtained from these series of
studies utilizing specific beta-adrenoreceptor agonist and
antagonist agents, add strong support to the concept that
the sympathetic nervous system directly regulates the secretion
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of renin from the juxtaglomerular cells of the mammalian
kidney through a receptor complex located on the membranes of
these cells which utilizes c-A11P as the intracellular
mediator.
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APPENDIX A

Renin Calculation

The concentration of renin in the incubated supernatant medium was calculated as follows:

ng/mg/hr

=

picograms A-I from
std. curve
X 40 X 2 X (40, 20, Or 10) X 2.5
2 X 1000 X mg wet tissue

where:
In numerator:
picograms A-I from std. curve = amount of unknown
sample read from std. curve •..
40

=

25 microliters of incubated sample diluted
in one ml of nephrectomized plasma for
generation •..

2

=

1:1 dilution of generated sample with
water prior to boiling ...

40, 20, or 10

=

whether 25, 50, or 100 microliters of
generated-boiled sample were used for
RIA ...

2.5

=

initial dilution in 2.5 ml of Robinson's
buffer medium prior to 1-hr incubation.
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where:
In denominator:
2

=

hours of incubation at 37°C •..

1000

=

conversion of picograms to nanograms ...

(mg wet tissue)=

amount of incubated kidney slice tissue.
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Legends

Figure 1.

Changes in renin release and c-AMP content in

renal cortical slices from sodium-deficient rats
compared to rats maintained on a sodium-replete diet
control.

Length of high- or low-dietary intake was 2-

3 weeks.

The sodium-deficient renin data represents

the mean change ± S.E. of 124 observations (number of
slice pairs) compared to 20 observations for the
sodium-replete data.

The corresponding c-AMP data are

based on 121 observations (sodium-deficient) compared
to 18 observations (sodium-replete).

The sodium-replete

(control) renin release rate was 1.38± 0.32 ng/mg/hr
and the c-AMP content was 0.64± 0.12 pMol/mg wet
tissue, respectively.

The incubation time was 60

minutes.
Figure 2.

Effect of various concentrations of 1-isopro-

terenol on renin release from renal cortical slices
of sodium-replete rats.

The data represent the mean

renin release change ± S.E. of 10 observations

54

55
(number of slice pairs) for each isoproterenol concentration.

The mean control (unstimulated) rate of

renin release was 1.38±0.3 ng/mg/hr during a 60 minute
incubation period.
Figure 3.

Effect of various concentrations of 1-isopro-

terenol on the c-AMP content of renal cortical slices
from sodium-replete rats.

The data represent the mean

+

c-AMP content change - S.E. of 8-9 observations (number
of slice pairs) for each isoproterenol concentration.
The mean control (unstimulated) c-AMP content was
0.64±0.1 pMol/mg wet tissue for a 60 minute incubation
period.
Figure 4.

Effect of various 1-isoproterenol doses on renin

release by renal cortical slices from sodium-deficient
rats.

The data represents the mean renin release

change

±

S.E. of 25-31 observations (number of slice

pairs) for each isoproterenol dose.

The mean control

(unstimulated) rate of renin release was 4.76± 0.36
ng/mg/hr during a 60 minute incubation period.
Figure 5.

Effect of various concentrations of 1-isopro-

terenol on renin release and c-AMP content of kidney
slices from sodium-deficient rats.

The renin data
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represents the mean renin release change

± S.E.

of

25-31 observations (number of slice pairs) for each
isoproterenol dose.
mean content change

The c-AMP data represents the

±

S.E. of 25-33 observations

(number of slice pairs) for each isoproterenol dose.
The mean control (unstimulated) rate of renin release
was 5.08 +
- 0.23 ng/mg/hr.
content was 0.48

±

The mean control c-AMP

0.1 pMol/mg wet tissue.

The in-

cubation time was 60 minutes.
Figure 6.

Changes in renin release and c-AMP content in

response to various 1-isoproterenol concentrations,
added either alone or together with 10

-4

M d,l-iso-

proterenol to renal cortical slices of rats fed a
sodium-deficient diet for 2-3 weeks.

The renin data

represents the mean renin release change +
- S.E. of
25-31 observations (number of slice pairs) for each
isoproterenol dose added alone, and 5-7 observations
for each isoproterenol dose added together with d,lpropranolol.

The c-AMP data represents the mean

content change +
- S.E. of 25-33 observations (number of
slice pairs) for each isoproterenol dose added alone,
and 6 observations for each isoproterenol dose added
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together with d,l-propranolol.

The mean control

(unstimulated) rate of renin release was 5.08
ng/mg/hr.

The mean control c-AMP content was 0.43

±o.l pMol/mg wet tissue.
60 minutes.

±o.23

The incubation time was
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